Fig. 2From: Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort studyComparison of S-IgG antibody titer in between patients treated with nintedanib vs pirfenidoneBack to article page